FDA Offers Final Draft of Best Practices for Postmarketing Safety Surveillance

Responding to changes required by the 21st Century Cures Act, the FDA has unveiled its principles for post market surveillance of drug safety in the final version of a 2019 draft on the subject.
Source: Drug Industry Daily